This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Starks Associates Inc., The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2020
Title: Krishnendu Roy: Innovator in Anticancer and Anti-inflammatory Research
Introduction
Krishnendu Roy is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel compounds with therapeutic potential. With a total of 2 patents, his work focuses on innovative solutions for health-related challenges.
Latest Patents
Roy's latest patents include "Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof." This patent discloses novel iodonium analogs that exhibit anticancer and anti-inflammatory activity. These compounds hold promise for advancing treatment options in oncology and inflammatory diseases.
Career Highlights
Throughout his career, Krishnendu Roy has worked with reputable organizations, including Starks Associates Inc. and the United States of America as represented by the Department of Health. His experience in these institutions has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Roy has collaborated with esteemed colleagues such as James Halpern Doroshow and Prabhakar Risbood. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful research outcomes.
Conclusion
In summary, Krishnendu Roy is a distinguished inventor whose work in developing iodonium analogs has the potential to revolutionize treatments for cancer and inflammatory conditions. His contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile